Literature DB >> 190648

Methyl xanthine phosphodiesterase inhibitors behave as prostaglandin antagonists in a perfused rat mesenteric artery preparation.

D F Horrobin, M S Manku, D J Franks, P Hamet.   

Abstract

The methyl xanthines, theophylline, caffeine and 3-isobutyl-1 methyl xanthine (MIX) inhibited the pressure responses to noradrnealine, angiotensin II and potassium ions in the isolated perfused mesenteric vascular bed of the male rat. The ID50s for inhibition of responses to noradrenaline were 1.85 mug/ml (0.83 x 10(-5) M) for MIX, 18 mug/ml (1 x 10(-4)M) for theophylline and 133 mug/ml (6.8 x 10(-4) M) for caffeine. Similar ID50 concentrations were found for responses to angiotensin II and potassium. We have previously found that substances which inhibit the three pressor agents equally may be prostaglandin (PG) synthesis inhibitors or PG antagonists. Xanthine itself, cyclic AMP and dibutyrl cyclic AMP had no inhibitory effects on the preparation up to concentrations of 10-2 M. Partial inhibition of PG synthesis by indomethacin shifted the % inhibition/log concentration curve to the left, while addition of exogenous PGE2 shifted it to the right. In preparations completely inhibited by sufficient indomethacin added to the perfusate to block PG synthesis, and then restored by adding 1 or 5 ng/ml PGE2 in addition to the indomethacin, the methyl xanthines again inhibited responses suggesting that they were PG antagonists rather than inhibitors of synthesis or release. In preliminary experiments MIX also inhibited effects of PGF2alpha on rat uterus and PGE1 on guinea pig ileum. Effective concentrations of theophylline were similar to the therapeutic levels in human plasma. PG antagonists may be a major action of methyl xanthines requiring reinterpretation of many experiments which have attributed their effects to PDE inhibition. PGs may also be involved in regulating PDE action.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 190648     DOI: 10.1016/0090-6980(77)90040-5

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  11 in total

1.  Apparent irrelevance of cyclic nucleotides to the relaxation of tracheal smooth muscle induced by theophylline.

Authors:  R C Kolbeck; W A Speir; G O Carrier; E D Bransome
Journal:  Lung       Date:  1979       Impact factor: 2.584

2.  Time-dependent effects of theophylline on myocardial reactive hyperaemias in the anaesthetized dog.

Authors:  J M Gidday; J W Esther; S W Ely; R Rubio; R M Berne
Journal:  Br J Pharmacol       Date:  1990-05       Impact factor: 8.739

3.  Effects of phosphodiesterase inhibitors on normal and chemically-skinned isolated airway smooth muscle.

Authors:  S E Bryson; I W Rodger
Journal:  Br J Pharmacol       Date:  1987-11       Impact factor: 8.739

4.  The effect of inhibition of prostaglandin synthesis on tubuloglomerular feedback in the rat kidney.

Authors:  J Schnermann; G Schubert; M Hermle; R Herbst; N T Stowe; S Yarimizu; P C Weber
Journal:  Pflugers Arch       Date:  1979-04-30       Impact factor: 3.657

Review 5.  Should bronchodilators be combined in chronic bronchitis and emphysema?

Authors:  D C Flenley
Journal:  Br Med J (Clin Res Ed)       Date:  1987-11-07

Review 6.  The management of status asthmaticus in infants and children.

Authors:  G Kurland; A B Leong
Journal:  Clin Rev Allergy       Date:  1985-02

7.  Severe acute asthma exacerbation in children: a stepwise approach for escalating therapy in a pediatric intensive care unit.

Authors:  I Federico Fernandez Nievas; Kanwaljeet J S Anand
Journal:  J Pediatr Pharmacol Ther       Date:  2013-04

Review 8.  Oral theophylline for chronic obstructive pulmonary disease.

Authors:  F S Ram; P W Jones; A A Castro; J A De Brito; A N Atallah; Y Lacasse; R Mazzini; R Goldstein; S Cendon
Journal:  Cochrane Database Syst Rev       Date:  2002

9.  The effect of theophylline on thyrotoxic tremor.

Authors:  D C Buss; D I Phillips; M D Littley; R W Marshall; P A Routledge; J H Lazarus
Journal:  Br J Clin Pharmacol       Date:  1989-07       Impact factor: 4.335

10.  Acute severe asthma: new approaches to assessment and treatment.

Authors:  Spyros A Papiris; Effrosyni D Manali; Likurgos Kolilekas; Christina Triantafillidou; Iraklis Tsangaris
Journal:  Drugs       Date:  2009       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.